Search clinical trials for: daclizumab (immunosuppressive)

Total 15032 results

UCB Biopharma SRL

Completed

A Study to Evaluate Rozanolixizumab in Study Participants With Generalized Myasthenia Gravis

Generalized Myasthenia Gravis

United States, Canada, Czechia, Denmark, France, Georgia, Germany, Italy, Japan, Poland, Russian Federation, Serbia, Spain, Taiwan
UCB Biopharma SRL

Completed

A Study to Investigate the Long-term Safety, Tolerability, and Efficacy of Rozanolixizumab in Adult Patients With Generalized Myasthenia Gravis

Generalized Myasthenia Gravis

United States, Canada, Czechia, Denmark, France, Germany, Italy, Japan, Poland, Russian Federation, Spain, Taiwan
GlaxoSmithKline
PPD

Completed

Belimumab (BENLYSTA®) Pregnancy Registry

Systemic Lupus Erythematosus

Belgium, Israel, United States, Italy, Argentina, Austria, Germany, Spain, Switzerland, France, Canada, Portugal, Sweden
Instituto de Investigación Hospital Universitario...
Hospital de Santa Maria, Portugal

Completed

Thymoglobulin in Cadaver Donor

Prevention of Kidney Injury Associated With Brain Death

Spain, Portugal
Hospital Authority, Hong Kong
Novartis Pharmaceuticals; The Hong Kong Blood Cancer Foundation

Unknown

Basiliximab for the Treatment of Acute Graft-versus-host Disease After Allogeneic Stem Cell Transplantation

Hematopoietic Stem Cell Transplantation | Graft vs Host Disease

China
GlaxoSmithKline

Recruiting

BENLYSTA® Special Drug Use Investigation

Systemic Lupus Erythematosus

Japan
Washington University School of Medicine
GlaxoSmithKline; American Cancer Society, Inc.

Completed

Belimumab for Prevention of Chronic Graft-versus-Host Disease Following Allogeneic Hematopoietic Cell Transplantation

Graft Vs Host Disease | Graft-versus-host-disease

United States
UCB Biopharma SRL

Completed

A Study to Assess Long-term Safety, Tolerability and Efficacy of Rozanolixizumab in Subjects With Chronic Inflammatory Demyelinating Polyradiculoneuropathy

Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)

United States, Belgium, Denmark, France, Germany, Netherlands, Spain, United Kingdom
University Hospital, Brest

Unknown

Comparison Thymoglobulin® and Grafalon® (THYGRET)

Renal Transplantation

France
Cedars-Sinai Medical Center
Genzyme, a Sanofi Company

Withdrawn

A Study to Compare the Effectiveness of a Drug That Suppresses the Immune System Called Thymoglobulin® in Preventing the Development of a Disease That Affects the Majority of Heart Transplant Recipients Called Cardiac Allograft Vasculopathy (CAV)

Cardiac Allograft Vasculopathy

United States
GlaxoSmithKline

Active, not recruiting

Study of Subcutaneous (SC) Belimumab in Pediatric Participants With Systemic Lupus Erythematosus (SLE)

Systemic Lupus Erythematosus

Mexico, Netherlands, United States, Germany, Spain, Argentina, Japan
GlaxoSmithKline
Human Genome Sciences Inc.

Completed

BEL114333, a Continuation Study of BEL113750 in Subjects With Systemic Lupus Erythematosus (SLE) in Northeast Asia, and in Japan Subjects Completing the Open-label Extension of HGS1006-C1115

Systemic Lupus Erythematosus

Korea, Republic of, Japan
GlaxoSmithKline
Human Genome Sciences Inc.

Completed

GSK1550188 A 52 Week Study of Belimumab Versus Placebo in the Treatment of Subjects With Systemic Lupus Erythematosus (SLE) Located in Northeast Asia

Systemic Lupus Erythematosus

Korea, Republic of, China, Japan
McGill University Health Centre/Research Institute...

Unknown

EXTEND Protocol for Transplanted Patient to Evaluate Kidney Function

Kidney Transplant

Canada
University Medical Center Groningen
Radboud University Medical Center; Maastricht University Medical Center; UMC... and other collaborators

Recruiting

Incidence, Course and Outcome of ABMR in Kidney Transplantation (PROCARE2)

Kidney Transplantation | Immunosuppression | Antibody-mediated Rejection

Netherlands
Xiaoli Fan

Recruiting

Remission Induction of Primary Biliary Cholangitis-autoimmune Hepatitis Overlap Syndrome

Cholangitis | Hepatitis, Autoimmune | Cholestasis | Liver Cirrhosis, Biliary

China
GlaxoSmithKline

Recruiting

Open-label Study of Belimumab Plus Standard Therapy in Chinese Pediatric Participants With Active Systemic Lupus Erythematosus (SLE)

Systemic Lupus Erythematosus

China
UCB Biopharma SRL

Terminated

A Study to Investigate the Long-term Safety, Tolerability, and Efficacy of Rozanolixizumab in Study Participants With Persistent or Chronic Primary Immune Thrombocytopenia (ITP) (myOpportunITy3)

Primary Immune Thrombocytopenia

United States, China, Georgia, Germany, Hungary, Italy, Japan, Moldova, Republic of, Poland, Russian Federation, Spain, Taiwan, Ukraine, United Kingdom
Fox Chase Cancer Center
Novartis Pharmaceuticals

Terminated

Sporadic Angiomyolipomas (AMLs) Growth Kinetics While on Everolimus (SAGE)

Sporadic Angiomyolipomas (AMLs)

United States
Yale University
Novartis Pharmaceuticals

Terminated

Neoadj ph 2 AI Plus Everolimus in Postmenopausal Women w/ ER Pos/HER2 Neg, Low Risk Score

Breast Cancer

United States
Assistance Publique - Hôpitaux de Paris

Active, not recruiting

Evaluation of Efficacy and Tolerance of Cladribine in Symptomatic Pulmonary Langerhans Cell Histiocytosis (ECLA)

Langerhans Cell Histiocytosis of Lung

France
GlaxoSmithKline

Completed

A Phase 2B Open-Label, Single-Arm, Repeat-Dose Study to Evaluate the Reliability of an Autoinjector

Systemic Lupus Erythematosus

United States
Novartis Pharmaceuticals

Completed

A Prospective, Open Label Study of CERtican in KIdney Transplantation (CERKI)

Kidney Transplant

Korea, Republic of
GlaxoSmithKline

Completed

The Evaluation of Belimumab in Myasthenia Gravis (MG)

Myasthaenia Gravis

United States, Canada, Germany, Italy
Indiana University School of Medicine

Completed

Basiliximab #2: In-Vivo Activated T-Cell Depletion to Prevent Graft-Versus_Host Disease (GVHD) After Nonmyeloablative Allotransplantation for the Treatment of Blood Cancer

Multiple Myeloma | Non-Hodgkin's Lymphoma | Myelofibrosis | Chronic Lymphocytic Leukemia | Anemia, Aplastic | Acute Lymphocytic Leukemia | Acute Myelogenous Leukemia | Chronic Myelogenous Leukemia | Myelodysplasia | Hemoglobinuria, Paroxysmal | Hodgkin's Disease

United States
Gustave Roussy, Cancer Campus, Grand Paris

Terminated

Assessing Everolimus in Fist Line Treatment on Patients With Metastatic Kidney Cancer (POORTOR)

Kidney Cancer

France
Herlev Hospital
Odense University Hospital; Aalborg University Hospital

Completed

Irinotecan, Cetuximab and Everolimus to Patients With Metastatic Colorectal Cancer (ICE)

Metastatic Colorectal Cancer

Denmark
Novartis Pharmaceuticals

Completed

Safety, Tolerability and Efficacy of Everolimus With Lower Versus Higher Levels of Tacrolimus in de Novo Renal Transplant Patients

Renal Transplantation
ElsaLys Biotech

Not yet recruiting

Evaluation of EFficacy and SaFEty of Leukotac (Inolimomab) in Pediatric Patients With SR-aGvHD (EiFFEL)

Steroid Refractory GVHD
xuna

Withdrawn

Belimumab for Treatment of cGVHD Following Allo-HCT

cGVHD

China
Ionis Pharmaceuticals, Inc.

Completed

ISIS 2302-CS22, A 6-Week, Active-Controlled Clinical Study to Evaluate the Effectiveness of Alicaforsen (ISIS 2302) in Patients With Mild to Moderate Active Ulcerative Colitis

Ulcerative Colitis

United States
Novartis Pharmaceuticals

Completed

RAMSETE: RAD001 in Advanced and Metastatic Silent Neuro-endocrine Tumors in Europe (RAMSETE/CDE16)

Carcinoma | Neuroendocrine | Advanced and Metastatic Silent Neuro-Endocrine Tumors | Non Functioning Neuroendocrine Tumors (NETs) | Non Syndromic Neuroendocrine Tumors | Carcinoids | Non Functioning

Sweden, Italy, Germany, United Kingdom, Spain, France, Netherlands, Poland
Atlantic Pharmaceuticals Ltd

Completed

Phase 1 Food Effect Study for Alicaforsen Tablets

IBD

United Kingdom
Oklahoma Medical Research Foundation
GlaxoSmithKline

Unknown

Evaluation of Belimumab Impact on a BLyS Activity Signature Test in the Absence of Confounding Polypharmacy (BLAST)

Systemic Lupus Erythematosus

United States
Novartis Pharmaceuticals

Completed

Efficacy and Safety of Everolimus (RAD001) in Patients With Advanced Gastric Cancer

Advanced Gastric Cancer

Japan
St. Jude Children's Research Hospital
Novartis

Completed

Everolimus for Treating Pediatric Patients With Recurrent or Refractory Tumors

Sarcoma, Soft Tissue | Brain Tumors | Rhabdomyosarcoma | Tumors

United States
Organisation for Oncology and Translational Research

Unknown

Everolimus in Breast Cancer Patients After Pre-operative Chemotherapy

Breast Neoplasms

China
Gustave Roussy, Cancer Campus, Grand Paris
Novartis

Unknown

Study to Evaluate RAD001 in Combination With Radiotherapy in Non-small Cell Lung Cancer (RAD001)

Non-small Cell Lung Cancer | Locally Advanced Disease

France
Hadassah Medical Organization

Completed

Thymoglobuline in Non-myeloablative Allogeneic Stem-cell Transplantation

Stem Cell Transplantation | Graft Vs Host Disease

Israel
Cerimon Pharmaceuticals
PPD

Terminated

The Safety and Efficacy of Basiliximab as Maintenance Therapy in Subjects With Stable, Noninfectious Uveitis (BSX-003)

Non-infectious Uveitis

United States
University of Nebraska

Terminated

Cardiac Allograft Remodeling and Effects of Sirolimus (CAR)

Cardiac Hypertrophy | Immunosuppression

United States
Maria Sklodowska-Curie National Research Institute...
KCRI

Not yet recruiting

Total Body Irradiation and Cladribine Before Allogeneic Hematopoietic Cell Transplantation in Patients With AML (Acute Myeloid Leukemia) and Myelodysplastic Syndromes (CLARA)

Acute Myeloid Leukemia Myelodysplastic Syndromes

Poland
Washington University School of Medicine
EMD Serono

Active, not recruiting

Cladribine Tablets: Collaborative Study to Evaluate Impact On Central Nervous System Biomarkers in Multiple Sclerosis (CLOCK-MS)

Multiple Sclerosis | Multiple Sclerosis, Relapsing-Remitting

United States
UCB Biopharma SRL

No longer available

CIDP07 Rozanolixizumab Post Trial Access Program (the PTA)

Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
ElsaLys Biotech

Available

Early Access Program With Inolimomab in Steroid-refractory Acute Graft Versus Host Disease

Steroid Resistant Acute Graft Versus Host Disease

France
GlaxoSmithKline

Completed

A Study of Belimumab in Idiopathic Membranous Glomerulonephropathy

Glomerulonephritis, Membranous

United Kingdom
International Extranodal Lymphoma Study Group (IELSG)

Completed

Multicenter Phase II Study to Evaluate the Clinical Activity and the Safety Profile of Everolimus in Marginal Zone B-cell Lymphomas (MZL)

Marginal Zone B-cell Lymphoma

Italy, Switzerland, Austria
Cerimon Pharmaceuticals

Completed

Basiliximab in Moderate to Severe Ulcerative Colitis

Ulcerative Colitis

United States, Poland, Belgium, United Kingdom, Czech Republic, Russian Federation, Slovakia, Ukraine, India
Alexion Pharmaceuticals, Inc.
AstraZeneca

Recruiting

Eculizumab in Pediatric and Adult Participants With Atypical Hemolytic Uremic Syndrome (aHUS) in China (Soliris)

Atypical Hemolytic Uremic

China
Ge Zheng

Recruiting

Study of Chidamide Combined With Cladribine in Refractory/Relapsed Acute Myeloid Leukemia

Acute Myeloid Leukemia

China

Search clinical trials for: daclizumab (immunosuppressive)

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Gabon

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations